Chromatin Licenses Gene Stacking Technology for Sugar cane to Syngenta

CHICAGO--(Business Wire)--
Chromatin Inc. announced today that it has entered into an exclusive worldwide
research and commercial license agreement with Syngenta Biotechnology Inc. for
Chromatin`s proprietary gene stacking technology in sugar cane.

Chromatin has developed a novel approach to gene stacking, using the plant`s own
DNA to deliver several genes. Under this agreement, Syngenta has obtained
exclusive rights to use Chromatin`s stacking technology for trait genes in all
plants from the genus Saccharum which includes commercial sugar cane varieties
as well as energy cane, and crosses between Saccharum and other plant species.
Syngenta obtained non-exclusive rights for use of this stacking technology in
corn and soybean in 2007.

"Sugar cane growers and processors will benefit economically and environmentally
from access to a combination of advanced traits that this technology could
make," said Ian Jepson, Global R&D sugar cane crop lead. "This new stacking
technology, combined with the advanced plant varieties, crop protection choices,
and our revolutionary new Plene technology will ensure our customers will have
the best solutions in sugar cane and will give us a leading position especially
in the large Brazilian market."

Sugar cane is among the top crops grown today for use in sugar production and
biofuels. Syngenta offers a broad range of crop protection products for sugar
cane growers and is developing a novel planting technology planned for launch in
2010 under the brand name Plene that will help reduce production costs. New
trait combinations in sugar cane could offer growers additional improvements in
production efficiency and yield increases.

"Chromatin is pleased to continue our work with Syngenta," said Daphne Preuss,
Chromatin`s CEO. "The broad Syngenta pipeline and crop production programs make
them an ideal partner for us in applying Chromatin`s gene stacking technology in
sugar cane worldwide."

Further terms of the deal were not disclosed.

Plene is a trademark of a Syngenta Group Company.

About Chromatin:

Chromatin, Inc. develops and markets novel proprietary technology that enables
gene stacks to be designed and incorporated into plant cells. Chromatin`s
technology can be used in any plant to simultaneously introduce multiple genes
while maintaining precise control of gene expression. Chromatin is developing
its technology for applications that benefit the agricultural, nutritional,
energy, pharmaceutical, and chemical sectors.

For additional information visit www.chromatininc.com or contact Daphne Preuss,
312-235-3612.

Chromatin Inc.
Daphne Preuss, 312-235-3612

Copyright Business Wire 2009